Andere talen Microba Life Sciences Limited

Aandelen

MAP

AU0000209868

Beurs gesloten - Australian S.E. Andere beurzen 07:53:50 15-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,185 ^AUD	+2,78%		+2,78%	+2,78%

10/04	Microba Life Sciences krijgt 6 miljoen Australische dollar belastingkorting voor boekjaar 2023; aandelen dalen 5%.	MT
13/03	Australische aandelen volgen stijgingen van collega's op Wall Street terwijl markt Amerikaanse inflatiecijfers negeert	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Microba's Revenue Climbs 297% in Fiscal Q3	23/04
Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5%	10/04
2,700,000 Options of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-APR-2024.	05/04
48,031,314 Ordinary Shares of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-APR-2024.	05/04
Australian Shares Track Gains of Wall Street Peers as Market Shrugs Off US Inflation Data	13/03
Microba Life Sciences Rise 9% Following Launch of MetaPanel Test With Sonic Healthcare	13/03
Microba Life Sciences Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
8,250,000 Options of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-FEB-2024.	05/02
54,500,297 Ordinary Shares of Microba Life Sciences Limited are subject to a Lock-Up Agreement Ending on 27-JAN-2024.	27/01
Weak Oil Prices, China's Property Woes Hold Down Australian Shares	07/12
Microba Life Sciences Validates Safety, Tolerability of Inflammatory Bowel Disease Therapy in Phase One Trial	07/12
Microba Life Sciences Completes Acquisition of UK Microbiome Testing Company; Shares Slide 5%	06/12
Microba Life Sciences Limited completed the acquisition of Invivo Clinical Limited.	05/12
Microba Life Sciences Signs Research Agreement with IFF Subsidiary to Develop Allergy Treatments	04/12
Microba Life Sciences' Domestica, International Personal Testing Revenue Rises in Fiscal Q1	19-10-23
Microba Life Sciences to Acquire Invivo Clinical	19-10-23
Microba Life Sciences Limited signed a binding share purchase agreement to acquire Invivo Clinical Limited for £11 million.	19-10-23
Microba Life Sciences Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30-08-23
Microba Life Sciences Completes Dosing for Phase One Trial of Biotherapeutic Product	25-08-23
Primer acuerdo de distribución firmado con Sonic Healthcare	05-07-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Microba Life Sciences Limited

Aandelen

MAP

AU0000209868

Andere talen

Filters